RVL Pharmaceuticals plc

Ownership Transactions Reported by 18 Insiders

Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, Bridgewater, NJ

There are no Buy or Sell transactions made by insiders since 10/21/2024

RVL Pharmaceuticals plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avista Healthcare Partners, L.P. 10%+ Owner $773K Aug 8, 2022
Athyrium Opportunities IV Acquisition 2 LP 10%+ Owner $201K Aug 8, 2022
Altchem Ltd 10%+ Owner $191K Oct 19, 2023
Harsaul Foundation 10%+ Owner $154K Oct 19, 2023
Brian A. Markison Chief Executive Officer, Director $92.9K Aug 8, 2022
James Schaub EVP and COO $16.4K May 18, 2023
Christopher Klein General Counsel & Secretary $5.63K May 18, 2023
Andrew J. Einhorn Chief Financial Officer $5.13K Jan 24, 2022
Tina Marie deVries EVP, Research & Development $4.25K May 18, 2022
Fred G. Weiss Director $3.7K Aug 27, 2021
Alisa Lask Director $3.51K Aug 10, 2023
Gregory L. Cowan Director $2.81K Jul 5, 2023
Michael J. DeBiasi Director $1.25K Jul 5, 2023
Avista Healthcare Partners GP, Ltd. 10%+ Owner Aug 15, 2023
Avista Capital Partners III GP, L.P. 10%+ Owner Jan 27, 2023
David Burgstahler Director, 10%+ Owner Jan 27, 2023
Sriram Venkataraman Director, 10%+ Owner Jan 27, 2023
Michael DePetris Principal Accounting Officer Apr 18, 2022

Recent Insider Transactions by Companies or Individuals for RVL Pharmaceuticals plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.